Theses

ALK7 obesity breakthrough featured in Science-Business eXchange

scibx-2014-1090-1
Article in Science-Business eXchange (SciBX) features ALK7 breakthrough discovery from Carlos Ibanez lab. SciBX’s Chris Cain quizzes Carlos Ibanez on the latest findings from the team, with comments from Alan Saltiel (University of Michigan) and John Knopf (CEO, Acceleron Pharma Inc.).
SciBX (2014) 7(37); doi:10.1038/scibx.2014.1090
Click on thumbnail to display PDF

ScienceDaily_Aug2014
Online research news outlet ScienceDaily highlights discovery of ALK7 link to catecholamine resistance in adipose tissue during obesity by Carlos Ibanez Lab. (Link to eLife paper HERE.) Click on thumbnail to display PDF. 

ALK7 papers featured in Science-Business eXchange


Article in Science-Business eXchange (SciBX) features the two 2008 PNAS papers on ALK7 functions in metabolism from Carlos Ibanez lab. SciBX’s Lev Osherovich quizzes Carlos Ibanez on the latest findings from his team, with comments from Prof. Se-Jin Lee (Johns Hopkins University) and Jasbir Seehra (CSO, Acceleron Pharma Inc.).
SciBX 1, 6-7 (2008)
Click on thumbnail to display PDF

SVT interview with Carlos Ibanez on ALK7 findings


YouTube : SVT interview with Carlos Ibanez

Evening news from Sveriges Television features Carlos Ibanez speaking about the latest discoveries from his team on the roles of the ALK7 receptor in the control of insulin levels and fat deposition. From Rapport May 12, 2008

Announcement of the Nobel Prize in Physiology or Medicine 2007


YouTube : TV4 interview with Carlos Ibanez

Swedish TV4 channel features Carlos Ibanez and Erna Moller speaking minutes before they walk into the Nobel Forum to take part in the Nobel Assembly vote on the Nobel Prize in Physiology or Medicine 2007. The prize went to Mario Capecchi, Martin Evans and Oliver Smithies for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells.